|
gptkbp:instance_of
|
gptkb:vaccine
|
|
gptkbp:adjuvant
|
not required
|
|
gptkbp:age_group
|
2 months
|
|
gptkbp:associated_with
|
mild fever
reduction in polio cases
|
|
gptkbp:available_on
|
single antigen vaccine
|
|
gptkbp:average_temperature
|
2 to 8 ° C
|
|
gptkbp:can_be_combined_with
|
gptkb:DTa_P_vaccine
|
|
gptkbp:clinical_trial
|
conducted before approval
|
|
gptkbp:contraindication
|
severe allergic reaction
|
|
gptkbp:country
|
globally
|
|
gptkbp:defense
|
included in EPI
|
|
gptkbp:developed_by
|
gptkb:Jonas_Salk
|
|
gptkbp:dosage_form
|
required
|
|
gptkbp:dose_schedule
|
3 doses
|
|
gptkbp:first_introduced
|
gptkb:1955
|
|
gptkbp:formulation
|
gptkb:liquid
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
inactivated polio vaccine (IPV)
|
|
gptkbp:impact_on_polio_eradication
|
gptkb:significant
|
|
gptkbp:influenced_by
|
gptkb:scientific_research
public health policies
vaccine hesitancy
|
|
gptkbp:introduced_in
|
developed countries first
|
|
gptkbp:is_compared_to
|
gptkb:oral_polio_vaccine_(OPV)
|
|
gptkbp:is_effective_against
|
gptkb:virus
high
wild poliovirus after initial vaccination
|
|
gptkbp:is_recommended_by
|
gptkb:CDC
gptkb:WHO
|
|
gptkbp:is_recommended_for
|
gptkb:children
|
|
gptkbp:is_vulnerable_to
|
induces antibody response
|
|
gptkbp:not_contagious
|
gptkb:true
|
|
gptkbp:not_live_virus
|
gptkb:true
|
|
gptkbp:not_oral
|
gptkb:true
|
|
gptkbp:not_prevent
|
non-polio enterovirus infections
|
|
gptkbp:part_of
|
gptkb:global_polio_eradication_initiative
combination vaccines
polio vaccination strategy
|
|
gptkbp:produced_by
|
various pharmaceutical companies
|
|
gptkbp:requires
|
cold chain management
multiple doses for full immunity
trained healthcare provider
|
|
gptkbp:route_of_administration
|
injection
|
|
gptkbp:safety
|
generally safe
|
|
gptkbp:side_effect
|
mild
|
|
gptkbp:targets
|
gptkb:poliomyelitis
|
|
gptkbp:type
|
inactivated vaccine
|
|
gptkbp:used_in
|
routine immunization programs
emergency vaccination campaigns
oral vaccination programs
|
|
gptkbp:bfsParent
|
gptkb:Salk_polio_vaccine
|
|
gptkbp:bfsLayer
|
6
|